Results 191 to 200 of about 323,203 (269)
Do we consider scalability from the outset? A methodological review of pilot randomised controlled health trials. [PDF]
Mclaughlin M +7 more
europepmc +1 more source
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober +16 more
wiley +1 more source
Beyond Numbers: Uses and Value of In-Trial Interview Data for Regulatory and Health Technology Assessment (HTA) Decision Making. [PDF]
Dias-Barbosa C +5 more
europepmc +1 more source
Enhancing lung health in children with structural damage and malformations: trial protocol for a randomised controlled trial of azithromycin for airway infection prevention. [PDF]
Rønne MN +7 more
europepmc +1 more source
Coenrollment of critically ill patients in PROSPECT: A protocol and statistical analysis plan. [PDF]
Thabane A +4 more
europepmc +1 more source
Reporting of dog-assisted intervention trials: extension of the SPIRIT 2025 and CONSORT 2025 statement. [PDF]
Hall SS +8 more
europepmc +1 more source

